Prognostic Value of Shock Index Creatinine in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic

Bangyuan Yang1, Changjin Wang1, Ting Zhou1

  • 1Department of Cardiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

Cardiorenal Medicine
|September 22, 2024
PubMed

Insights

The shock index creatinine (SIC) effectively predicts mid-term mortality in severe aortic stenosis patients undergoing transcatheter aortic valve replacement (TAVR). High SIC indicates increased frailty, cardiac damage, and higher mortality risk post-TAVR.

Area of Science:

  • Cardiology
  • Medical Diagnostics
  • Prognostic Biomarkers

Background:

  • Shock index (SI) and its derivatives are recognized for prognostic value in cardiovascular diseases.
  • Severe aortic stenosis (AS) management often involves transcatheter aortic valve replacement (TAVR).

Purpose of the Study:

  • To evaluate the predictive capability of shock index creatinine (SIC) for mid-term mortality in severe AS patients undergoing TAVR.
  • To assess the association between SIC and patient characteristics, comorbidities, and perioperative complications.

Main Methods:

  • Retrospective analysis of 555 severe AS patients undergoing TAVR.
  • Calculation of SIC: (SI × 100) - estimated creatinine clearance (CCr).
  • Primary endpoint: all-cause mortality; secondary endpoints: VARC-3 complications; statistical analyses: ROC curve, Cox regression, restricted cubic spline (RCS).

Main Results:

  • A high SIC (cutoff 16.5) was associated with significantly higher cumulative all-cause mortality (18.3% vs. 5.2%, p < 0.001).
  • Patients with high SIC were older, more frail, and had higher rates of moderate/severe mitral regurgitation, tricuspid regurgitation, and pulmonary hypertension.
  • High SIC correlated with increased acute kidney injury (10.1% vs. 3.9%, p = 0.008) and bleeding (13.6% vs. 6.7%, p = 0.014).
  • RCS confirmed a positive correlation between SIC and mortality; incorporating SIC improved the STS score's predictive value for 1-year mortality (AUC 0.731 vs. 0.649, p = 0.01).

Conclusions:

  • Elevated SIC in severe AS patients undergoing TAVR signifies increased frailty, cardiac damage, and heightened in-hospital and mid-term mortality risk.
  • SIC serves as a valuable tool for refining risk stratification in TAVR candidates.
Abstract

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...